Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04849364
Title Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE)
Acronym PERSEVERE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bryan Schneider, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.